Drug Detail:Comirnaty (Covid-19 vaccine, mrna)
Generic Name: TOZINAMERAN 0.225mg in 2.25mL
Dosage Form: injection, suspension
Drug Class: Viral vaccines
For intramuscular injection only.
The storage, preparation, and administration information in this Prescribing Information apply to COMIRNATY supplied in:
- •
- single dose vials with gray caps and labels with gray borders, and
- •
- multiple dose vials with gray caps and labels with gray borders.
COMIRNATY supplied in vials with gray caps and labels with gray borders MUST NOT be diluted prior to use.
Preparation for Administration
- •
- COMIRNATY vials with gray caps and labels with gray borders contain a frozen suspension without preservative. Each vial must be thawed prior to administration. DO NOT DILUTE prior to use.
- •
- Vials may be thawed in the refrigerator [2ºC to 8ºC (35ºF to 46ºF)] or at room temperature [up to 25ºC (77ºF)].
- •
- Refer to thawing and preparation instructions in the panels below.
Administration Information
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. The vaccine will be a white to off-white suspension. Do not administer if vaccine is discolored or contains particulate matter.
After withdrawing a single 0.3 mL dose of COMIRNATY, administer immediately.
Vaccination Schedule
COMIRNATY is administered intramuscularly as a series of 2 doses (0.3 mL each) 3 weeks apart.
There are no data available on the interchangeability of COMIRNATY with COVID-19 vaccines from other manufacturers to complete the vaccination series. Individuals who have received 1 dose of COMIRNATY should receive a second dose of COMIRNATY to complete the vaccination series.